NIH modernizes its pharmaceutical development service

Traynor, Kate
May 2010
American Journal of Health-System Pharmacy;5/1/2010, Vol. 67 Issue 9, p698
Academic Journal
The article reports on the modernization of the Pharmaceutical Development Section (PDS) at the National Institutes of Health (NIH) in the U.S. It notes that more elbowroom and improved technology will be installed at the PDS to better serve its patients. Its new area includes a positive- and negative-pressure rooms and high-efficiency particulate-absorbing filters. The area also includes a plumbing system.


Related Articles

  • Deadly Medicine. BARLETT, DONALD L.; STEELE, JAMES B. // Vanity Fair;Jan2011, Issue 605, p56 

    The article explores the reported execution of drug clinical trials in foreign countries by pharmaceutical companies to obtain approval from the U.S. Food and Drug Administration (FDA). The information compiled by the National Institutes of Health (NIH) on the number of overseas trials conducted...

  • News @ a glance. Webster, Paul; Sibbald, Barbara // CMAJ: Canadian Medical Association Journal;3/15/2005, Vol. 172 Issue 6, p736 

    Presents news briefs on issues concerning medical care as of March 15, 2005. Explanation on the microarray test, the first DNA laboratory test system approved by the U.S. Food & Drug Administration; Details of the revised Code of Conduct from Canada's Research-Based Pharmaceutical Companies;...

  • BUSINESS AND PEOPLE UPDATE.  // Applied Clinical Trials;Aug2010, Vol. 19 Issue 8, p47 

    The article offers news briefs on the pharmaceutical industry in the U.S. The Food and Drug Administration (FDA) and the National Institute of Health have launched the Safety Reporting Portal Web site. Almac has launched the XCEL array, a biomarker discovery platform that enables the...

  • Sun Pharma Doesn't Want Lethal Injection Used for Executions.  // India -- West;10/2/2015, Vol. 40 Issue 46, pA42 

    No abstract available.

  • Cures Act bill meets mixed reception, moves to Senate. Satter, Marlene Y. // BenefitsPRO;12/6/2016, p1 

    The bipartisan 21st Century Cures Act, headed to the Senate after passage in the House by a huge margin--392 to 26--is meeting with mixed reactions ...

  • Agencies Prepare for Hair Trigger of Sequestration. Serebrov, Mari // BioWorld Today;2/12/2013, Vol. 24 Issue 29, p1 

    The article focuses on the efforts of several federal agencies to prepare for the impacts of sequestration to the biopharmaceutical industry. It states that the U.S. Food and Drug Administration (FDA), National Institutes of Health (NIH), and other entities sent notices to their employees...

  • Noted...  // Medical Design Technology;Feb2005, Vol. 9 Issue 2, p8 

    Reports developments in the pharmaceutical industry in the U.S. Agreement between Edwards Lifesciences Corp. and Saint Jude Medical Inc.; Goals of U.S. National Institute of Health's cross-cutting Action Plan for Liver Disease Research; Effort of the U.S. Food and Drug Administration to get the...

  • Experts Ponder Ways to Fill Pharma Pipeline. Wechsler, Jill // Pharmaceutical Technology;May2011, Vol. 35 Issue 5, p28 

    The article addresses the importance of adopting new business models to improve the condition of the pharmaceutical industry in the U.S. It outlines the plan of Pfizer Inc. to reduce its budget for research and development (R&D) by six to seven billion dollars by 2012 which reflects the crisis...

  • Clinic Roundup.  // BioWorld Today;8/6/2010, Vol. 21 Issue 151, p3 

    This section offers news briefs related to the pharmaceutical industry as of August 6, 2010. Professor Jacek Pinski has been given 1.5 million three-year grant by Aeterna Zentaris Inc. and the National Institutes of Health to study the firm's AEZS-108. Dyax Corp. reported that patients with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics